Subgroup analyses in randomised controlled trials: Quantifying the risks of false-positives and false-negatives

Health Technology Assessment

Volumn 5, Issue 33, 2001, Pages

  Brookes, S T ^a   Whitley, E ^a   Peters, T J ^a   Mulheran, P A ^a   Egger, M ^a   Davey Smith, G ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ANALYTICAL ERROR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; FACTORIAL ANALYSIS; INFORMATION PROCESSING; METHODOLOGY; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RESEARCH; REVIEW; RISK ASSESSMENT; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL CONCEPTS; STATISTICAL MODEL; STATISTICAL PARAMETERS;

EID: 0034799451     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta5330     Document Type: Review

References (31)

1. Statistical problems in the reporting of clinical trials. A survey of three medical journals
2. Subgroup analysis and other (mis)uses of baseline data in clinical trials
3. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
4. Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial)
5. Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation
6. On wisdom after the event
7. On reaching the tunnel at the end of the light
8. Incommunicable knowledge? Interpreting and applying the results of clinical trial and meta-analyses
9. The problem of cogent subgroups: A clinicostatistical tragedy
10. Effect of peer led programme for asthma education in adolescents: Cluster randomised controlled trial
11. Anxiety among women with mild dyskaryosis: A randomized trial of an educational intervention
12. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
13. Assessing apparent treatment-covariate interactions in randomized clinical trials
14. The design and analysis of randomized controlled trials of treatments for lower urinary tract symptoms
15. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomized trials
16. Strategies for subgroup analysis in clinical trials
17. Bias in location and selection of studies
18. The use and abuse of subgroup analysis in epidemiological research
19. Estimation issues in clinical trials and overviews
20. Subgroup analysis
21. A consumers guide to subgroup analyses
22. Sifting the evidence - What's wrong with significance tests?
23. The design of case-control studies: The influence of confounding and interaction effects
24. On power and sample size for studying features of the relative odds of disease
25. Power and sample size calculations in case-control studies of gene-environmental interactions: Comments on different approaches